| 
Results for vaccines therapeutics. Search took 0.14 seconds.
Drug pushing Eli Lilly
in Sox First, on June 13, 2009
...
With drug companies around the world set to make millions selling vaccines to stop swine flu, it's worth looking at how they are pushing drugs. Bloomberg reports that drug giant Eli Lilly p...
Health supply chains in Africa to be discussed in CSCMP 2009 conference
in Supplychainer, on June 9, 2009
...ain insights in this area. At the center of the international issue of improving delivery of drugs, vaccines, and other remedies to needy populations is the role of the supply chain. The session, enti...
Google to Invest in Biotechnology
in The Biotech Weblog, on April 2, 2009
...in View, Calif.
Google is open to funding biotechnology start-ups. "If we find an interesting therapeutics company, we'd be happy to put down a term sheet," Maris said.
Read the entire...
MIT Sloan BioInnovations Conference
in Straightfromthedoc, on March 5, 2009
...g:
Naseem Amin, M.D. PhD; SVP, Business Development, Biogen Idec
Andrin Oswald, M.D.; CEO, Novartis Vaccines
Panels will include:
Entrepreneurship: Making Your Company a Success
Lesa Mitchell (Kauff...
Genetic Sequencing of Cold Virus
in The Biotech Weblog, on February 19, 2009
... the different strains can be used in epidemiologic studies and in the development of antivirals or vaccines against human rhinoviruses.
This study has been published in the Feb 13, 2009 issue of Sc...
Nominations Open for the Biotech Humanitarian Award
in The Biotech Weblog, on January 13, 2009
...r, philanthropist or educator - whose work in biotechnology made significant impact in the areas of therapeutics, food and agriculture, or industrial or environmental applications.
Qualified nominees...
Distribution of Contraceptives, Approved at Gloucester
in Next Nine Months, on October 9, 2008
...be guided and educated well in terms of pregnancy, sex and even cervical cancer and cervical cancer vaccines. The education of course starts at home. And I agree with the distribution of contraceptive...
Vaccine Allergies
in Allergies, on September 11, 2008
...ll, so am I!
With my first-born, it never even occurred to me to worry about allergic reactions to vaccines. Allergies was something that happened to other people, not us. Well, nothing untoward happ...
Nanotubes Punching Holes in Cancer
in Nanotechbuzz, on August 28, 2008
...icity, and more effective treatment of cancer. The future of cancer care will involve more targeted therapeutics on molecular and nano-mechanical levels. Source: Stanford News
...
2008-2009 Flu Vaccines, Approved By The FDA
in Straightfromthedoc, on August 10, 2008
...rtesy of iStockphoto, shannon drawe
Earlier this week, the FDA has announced its approved flu vaccines for the 2008-2009 flu season in the United States.
Six vaccines approved and their manufa...
Phase 1 Trials Shows Plant-Produced Cancer Vaccine as Safe
in The Biotech Weblog, on July 28, 2008
...for patients. If further trials demonstrate its efficacy, this presents a novel method of producing vaccines quickly and cheaply.
The researchers chose tobacco plants that were genetically modified ...
Genetically Modified Salmonella Delivers Vaccine
in The Biotech Weblog, on July 17, 2008
...otein from the S. pneumoniae bacterium, which then triggers a strong antibody response. Unlike most vaccines that are entirely manufactured by a vaccine company, the attenuated recombinant salmonella ...
Celebrity Green Team
in The Celebrities Weblog, on June 12, 2008
...rally attended by Jim Carrey, Jenny McCarthy and other celebrities aimed at eliminating toxins in vaccines.
Source:www.people.com
...
Instantly Stop Bleeding
in Nanotechbuzz, on May 28, 2008
...certain individuals who have bleeding disorders such as hemophilia .
A company called Arch Therapeutics has licensed special technology from MIT and is developing a material that may instant...
Top Ten Cool Hedge Fund Moves
in The Hedge Funds Weblog, on January 4, 2008
...ipotle Mexican Grill
Firm: Tremblant Capital Group
Profit: $95 million
Top Trade #10: United Therapeutics Corp.
Firm: Shunway Capital Partners
Profit: $73 million
...
Hib Vaccine Recalled
in The Parenting Weblog, on December 13, 2007
...are no longer "special" when it comes to product recalls . Now, even children's vaccines are being recalled.
More than a million vaccines of Hib and combination vaccines Hib and H...
Beware of Poory Refrigerated Vaccines
in The Parenting Weblog, on December 4, 2007
... photo
Watch out for poorly refrigerated vaccines, parents! After comforting you child after his or her vaccine ordeal, it is possible that that vaccine is a dud. The Center for Disease Control a...
More Evidence that Alzheimer's is A Type 3 Diabetes
in Daily Diabetic, on November 30, 2007
...shes, "the insulin receptors disappeared from their surfaces."
This just means that new therapeutics in both diabetes and Alzheimer's can potentially be developed in lieu of such findi...
Cannabis Compound Can Potentially Fight Metastatic Breast Cancer
in Straightfromthedoc, on November 25, 2007
...tive it is still considered a Schedule 1 drug.
Findings appear in the journal Molecular Cancer Therapeutics .
Source: California Pacific Medical Center Research Institute (a pdf file)
...
Fish Oil, Good Supplemental Treatment for Lupus
in Straightfromthedoc, on November 13, 2007
...al function.
According to Stephen Wright, MD, specialist registrar in rheumatology, department of therapeutics and musculoskeletal education & research unit, Queen's University of Belfast, ...
Merck's HPV Vaccine May Expand to Women Up to 45 Years Old
in Well Woman Blog, on November 8, 2007
...ned it to me. Unfortunately, it's a disease very few women know about and should. At first, the vaccines for HPV was for young girls and women aged 9 to 26. Now, it looks like the vaccines can hel...
Peptide Therapeutics Symposium
in The Biotech Weblog, on November 5, 2007
... What : San Diego's 2nd Annual peptide Therapeutics Symposium
When : November 10, 2007
Where : The Hilton, La Jolla Torrey Pines, CA
Internationally acclaimed speakers from will prov...
Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status
in The Biotech Weblog, on October 30, 2007
... National Cancer Institute /NIAID Inter-Institute Program for the Development of AIDS-related Therapeutics. NIAID licensed the SQ109 technology to Sequella in March 2006 under a Cooperative Rese...
Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
in The Biotech Weblog, on October 25, 2007
...py using flavopiridol (an investigational anti-cancer agent that also boosts the effects of other therapeutics including cisplatin) with cisplatin (a platinum compound) for women with platinum-resi...
Tea Helps Strengthen Hips
in Well Woman Blog, on October 16, 2007
...otentially helpful," said Paul Brandt, an associate professor of neuroscience and experimental therapeutics at Texas A&M Health Science Center College of Medicine. "One or two cups of te...
Pregnant Women Should Eat More Fish?
in Well Woman Blog, on October 4, 2007
...e from people exposed in chemical spills. No major studies have shown evidence mercury from food or vaccines has caused brain damage to mothers or children.
Michael Bender, director of The Mercury Po...
Alzheimer's Disease: Type 3 Diabetes?
in Daily Diabetic, on September 27, 2007
...
This fundamental connection between the two conditions offers hope for the development of future therapeutics.
Source: Science Daily ; FASEBJ Abstract
...
Nasal Influenza Vaccine Flumist®, Now FDA-Approved for Children Ages 2-5
in Straightfromthedoc, on September 20, 2007
...ed in the nose.
Find more details from the FDA News .
Flumist® is a product of MedImmune Vaccines, Inc. .
[Photo Credit: Nature ]...
Red Wine Diet
in Celebrate Wine, on September 19, 2007
...s published by avery (326 pages, $15.95). Corder is a cardiovascular expert and professor of therapeutics at London's William Harvey Research Institute....
BIO Investor Forum 2007
in The Biotech Weblog, on September 7, 2007
...d Inflammatory Diseases - Clinical Perspective on New Treatment Paradigms and Targets
From Cancer Vaccines to Adjuvants - Insights into the Future of Immunotherapy and Cancer
Se the BIO Invest...
Human Source of Stem Cells With Potential To Repair Muscle Damaged by Disease or Injury
in The Biotech Weblog, on September 5, 2007
Scientists have isolated stem cells from blood vessels (known as myoendothelial cells) which can be differentiated in the laboratory into muscle, bone and cartilage cells and are thus suitable for use as a potential therapy for muscle injuries and diseases including heart attack and muscle dystro...
Symposium: Regulatory RNA in Biology and Human Health
in The Biotech Weblog, on August 28, 2007
...and biogenesis of small regulatory RNAs and how this is being applied to create a new generation of therapeutics and diagnostics.
The main topics to be discussed in this symposium includes:
Mech...
Elixir Pharma's Type 2 Diabetes Drug Mitiglinide Enters Phase III Clinical Trial
in Daily Diabetic, on August 22, 2007
...cal Advisory Board:
"There continues to be a tremendous unmet medical need in the U.S. for therapeutics that can be used alone or in combination with other drugs to provide patients with type 2...
About Generex's Oral-Lyn™ Oral Insulin Spray
in Daily Diabetic, on August 17, 2007
...s are yielding promising results, as was recently published in Diabetes Technology & Therapeutics (article title: Comparison of Oral Insulin Spray and Subcutaneous Regular Insulin at Mealtime i...
DNA Vaccine Against Multiple Scclerosis Appears Safe
in The Biotech Weblog, on August 15, 2007
...
Results of a clinical trial funded by Bayhill Therapeutics, Inc. shows that BHT-3009 , a newly developed DNA vaccine against multiple sclerosis appears safe and may produce beneficial changes...
Summer Time, Pollen Allergy Time
in Allergies, on August 13, 2007
...lly matter. When this season is over, consult your allergist and find out if immunotherapy (allergy vaccines) is something you could try in preparation for next year's allergy season. It does take...
Pollinex Quattro Hay Fever Vaccine Clinical Studies on Hold
in Allergies, on August 7, 2007
... Late last year, there were high hopes on Allergy Therapeutics ' new version of ragweed allergy vaccine called Pollinex Quattro , which has entered the last stages of development. Unlik...
Dynavax Technologies Corp. Received $30 Million for Allergy Franchise
in Allergies, on July 25, 2007
...verse immunologic response in allergic diseases.
Given the market opportunities associated with therapeutics targeting these areas, Deerfield has partnered with us in this venture and agreed to shar...
Brustvergroeßerung, natuerlich, mit Stammzellen aus eigenem Fettgewebe
in Das Gesundheits-Weblog, on July 10, 2007
...ntnommen. Aus diesem werden mit einem vom kalifornischen Biotechnologieunternehmen Cytori Therapeutics entwickelten Gerät innerhalb von nur einer Stunde Fett-Stammzellen isoliert und angereichert. Ans...
Transgenic Mushrooms as Drug Biofactories
in The Biotech Weblog, on June 25, 2007
...nsgenic mushrooms can then be used as factories for the production of therapeutic proteins, such as vaccines, monoclonal antibodies, and hormones like insulin, or commercial enzymes, such as cellulase...
Protein May Prevent Eye Damage in Preemies
in Straightfromthedoc, on June 20, 2007
...s for retinopathy of prematurity.
According to Dr. Maria B. Grant, a professor of pharmacology and therapeutics at UF's College of Medicine:
"We've identified a protein that is part of...
Costing Health
in Audeamus - How dare we..., on April 30, 2007
(image via article at CBS)
CBS News reports "If you have ever wondered why the cost of prescription drugs in the United States are the highest in the world or why it's illegal to import cheaper drugs from Canada or Mexico, you need look no further than the pharmaceutical lobby and its...
MBAs to the rescue
in Sox First, on April 27, 2007
..., and for as little as 1 month. MBAs Without Borders will pay for accommodation, transport, laptop, vaccines, health & travel insurance and visas. It also provides a $US1000 per month stipend, ret...
PTC124 Drug Candidate Against Duchenne Muscular Dystrophy and Other Genetic Diseases
in The Biotech Weblog, on April 25, 2007
Scientists report of a new prototype drug, designed to treat Duchenne muscular dystrophy but which may be useful in the treatment of up 1800 different genetic diseases. The drug, called PTC124 , has restored muscle function in mice trials.
Normal cells assemble amino acids into protein molecu...
Vaccine for Breast Cancer
in Well Woman Blog, on April 23, 2007
...e topic:
A vaccine is a very common way of building up the immune system to fight infection. Using vaccines to fight breast cancer is relatively new, however, and still considered experimental. A vac...
ADHD Children Who Start on Strattera® More Likely to Change Therapies, Study Says
in Straightfromthedoc, on April 19, 2007
...ere initially used.
Such were the results of a study conducted by pharmacy benefit manager Prime Therapeutics LLC (Prime) .
In lieu of such results, Prime has developed programs that promote the u...
Snake Venom Toxin Inhibits Human Prostate Cancer Cell Growth
in The Biotech Weblog, on April 16, 2007
... A study published in a recent issue of Molecular Cancer Therapeutics report on the effectiveness of the snake venom toxin (SVT) Vipera lebetina turanica in the inhibition of androgen -i...
Roche Licences Transgene's HPV Vaccines
in The Biotech Weblog, on April 12, 2007
Roche and Transgene will collaborate to develop and market products from Transgene's vaccine program against HPV-mediated diseases, including Transgene's main vaccine candidate TG 4001 , currently in development to treat high grade cervical intraepithelial neoplasia , a pre-cancerou...
On Ear Infections in Children and Pneumococcal Conjugate Vaccine (PCV7)
in Straightfromthedoc, on April 12, 2007
...terrible and so most children would just stay away from them like they're lepers or something.
Vaccines, in those days here in my home country, were really scarce - probably the reason why ear in...
Rabies-based Vaccine May Defeat HIV
in Straightfromthedoc, on April 11, 2007
...tors are based on a type of rabies vaccine strain that has been used for more than 20 years in oral vaccines against rabies in wildlife in Europe.
The study was aimed at studying the safety and effec...
Something to Watch
in The Hedge Funds Weblog, on March 30, 2007
...Interesting article here; Osiris Rises on Heart-Treatment News .
Investors bid up Osiris Therapeutics stock by 13.6% to $20.33 per share in early trading on the Nasdaq on March 26 after the company&...
Most Physicians Favor HPV Vaccination
in Straightfromthedoc, on March 29, 2007
...he HPV vaccine should not be mandated
more than two-thirds of physicians surveyed said only "vaccines for diseases that pose a significant risk of death and contagion" should be mandated a...
Pregnancy and Back Pain
in Well Woman Blog, on March 15, 2007
... reports on a recent study:
The study, published in the Journal of Manipulative and Physiological Therapeutics, says despite the high prevalence of musculoskeletal pain during pregnancy, few women i...
Final Four
in Businesspundit, on March 13, 2007
There seems to be a canyon-wide disconnect between the ivory towers of theoretical academia and the reality of industry and commercial applications. The Institute for Technology Entrepreneurship and Commercialization (ITEC) at Boston University is aiming to bridge that gap with its 7th Annual Busin...
Fruit Fly Offers Clues in Development of New Human Vaccines
in The Biotech Weblog, on March 13, 2007
...ns can now learn from flies, for this new finding has implications for new ways of developing human vaccines against AIDS and diseases that attack the immune system and also against bioterrorism ...
Michael J. Fox to Deliver Keynote Address at 2007 BIO International Convention
in The Biotech Weblog, on March 2, 2007
....
The discussion will explore strategies and solutions to "de-risk" investment in novel therapeutics for the biotechnology industry and academia alike.
Read the full report .
...
Flo Shots and Pregnancy
in Well Woman Blog, on February 14, 2007
...because it can protect both her and her baby, a new study released in San Francisco says.
Current vaccines are not licensed for babies under 6 months. But, the study says it appears that an expectan...
Adipose-Derived Stem Cell Therapy for Cardiovascular Disease
in The Biotech Weblog, on February 9, 2007
...
Cytori Therapeutics , a biotech firm developing stem and regenerative cell therapies for cardiovascular diseases treated their first patient in a hospital in Spain as part of Cytori's randomi...
War is Much More Harmful Than You Thought
in Latina Viva, on February 5, 2007
..., respiratory infections and diarrhea, could be saved, since these illnesses can be prevented by $2 vaccines, $1 worth of antibiotics, or a 10-cent dose of oral rehydration salts as well as the main b...
Chromium Picolinate: Best Chromium Form to Clinically Benefit Diabetics
in Straightfromthedoc, on February 2, 2007
...d analysis of Chromium Picolinate , published in the current edition of Diabetes Technology & Therapeutics , confirms that chromium picolinate is effective in improving glycemic control a...
Evaluating Press Releases Before Buying Biotech Stocks
in The Biotech Weblog, on January 22, 2007
...you need?
Adam Feuerstein offers valuable insights in interpreting press releases , taking Point Therapeutics ' press release as a case in point.
...
Biotechnology in 2007
in The Biotech Weblog, on January 4, 2007
...echnology. Care to make predictions? In what areas do you think we'll make big progress on? New therapeutics? Economically feasible alternative energy sources? Novel technology in agriculture and ...
Less Allergies in 2007!
in Allergies, on January 4, 2007
...search and development, so they'd come up with more effective and safer allergy medications and vaccines. I wish more people would be more aware and understand the dangers of allergies. I wish 200...
Protein Biomarkers for Alzheimer's Disease
in The Biotech Weblog, on December 14, 2006
... aid in the early detection and diagnosis of AD, but also help in identifying and testing potential therapeutics.
[Image: Three-dimensional visualization of part of the spinal fluid protein bar code ...
Using RNAi Technology Against BSE and CJD
in The Biotech Weblog, on December 10, 2006
... Scientists may be on to a novel approach for the development of therapeutics against neurodegenerative diseases such as Bovine spongiform encephalopathy (BSE, also known as "mad cow dis...
Modified Akt1 Enzyme Boost Efficacy of Tumor Vaccines
in The Biotech Weblog, on December 5, 2006
...
Scientists have come up with an altered enzyme Akt1 which can boost the effect of tumor vaccines by extending the lives of dendritic cells , the immune-system master switches that promote the r...
Pollinex Quattro Ragweed Allergy Vaccine Enters Last Stages of Development
in Allergies, on November 24, 2006
... Allergy Therapeutics , the makers of ragweed allergy vaccine Pollinex-R , are making headway with a new version of ragweed allergy vaccine called Pollinex Quattro Ragweed. This new formulation ...
Breast Cancer Vaccine Targeting HER-2/neu Over-expression
in The Biotech Weblog, on November 13, 2006
...y of disease, recurrence and overall survival. Reasearchers are now using these findings to develop vaccines targeting these genetic markers.
In a study presented during the recently held meeting of ...
The Netherlands Invested Euro 18.4 Million to Make Better Vaccines to Fight Raging TB Pandemic
in Straightfromthedoc, on November 7, 2006
...g stand by providing funding and scientific expertise for the development of new, more effective TB vaccines.
The Dutch Ministry of Foreign Affairs (DGIS) has invested Euro 18.4 million in Aeras G...
Drug Discovery Firm e-Therapeutics Screens South American Forests for Lead Compounds
in The Biotech Weblog, on November 6, 2006
...
e-Therapeutics , a spin off biotech company from Newcastle University has partnered with Brazilian company Grupo TCI to establish a joint research facility close to the Amazonian and Atlantic r...
